Characterization of the Epstein–Barr virus BALF2 promoter

References

1. Chang Y. N., Dong D. L., Hayward G. S., Hayward S. D. 1990; The Epstein–Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. Journal of Virology 64:3358–3369
   [Google Scholar]
2. Chang P.-J., Chang Y.-S., Liu S.-T. 1998a; Characterization of the BcLF1 promoter in Epstein–Barr virus. Journal of General Virology 79:2003–2006
   [Google Scholar]
3. Chang P. J., Chang Y. S., Liu S. T. 1998b; Role of Rta in the translation of bicistronic BZLF1 of Epstein–Barr virus. Journal of Virology 72:5128–5136
   [Google Scholar]
4. Chavrier P., Gruffat H., Chevallier-Greco A., Buisson M., Sergeant A. 1989; The Epstein–Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities. Journal of Virology 63:607–614
   [Google Scholar]
5. Chevallier-Greco A., Gruffat H., Manet E., Calender A., Sergeant A. 1989; The Epstein–Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. Journal of Virology 63:615–623
   [Google Scholar]
6. Cox M. A., Leahy J., Hardwick J. M. 1990; An enhancer within the divergent promoter of Epstein–Barr virus responds synergistically to the R and Z transactivators. Journal of Virology 64:313–321
   [Google Scholar]
7. Decaussin G., Leclerc V., Ooka T. 1995; The lytic cycle of Epstein–Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. Journal of Virology 69:7309–7314
   [Google Scholar]
8. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S. 1987; Firefly luciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology 7:725–737
   [Google Scholar]
9. Fixman E. D., Hayward G. S., Hayward S. D. 1992; Trans-acting requirements for replication of Epstein–Barr virus ori-Lyt. Journal of Virology 66:5030–5039
   [Google Scholar]
10. Furnari F. B., Adams M. D., Pagano J. S. 1992; Regulation of the Epstein–Barr virus DNA polymerase gene. Journal of Virology 66:2837–2845
    [Google Scholar]
11. Gruffat H., Sergeant A. 1994; Characterization of the DNA- binding site repertoire for the Epstein–Barr virus transcription factor R. Nucleic Acids Research 22:1172–1178
    [Google Scholar]
12. Holley-Guthrie E. A., Quinlivan E. B., Mar E. C., Kenney S. 1990; The Epstein–Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. Journal of Virology 64:3753–3759
    [Google Scholar]
13. Luka J., Kallin B., Klein G. 1979; Induction of the Epstein–Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94:228–231
    [Google Scholar]
14. Nonoyama M., Pagano J. S. 1972; Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein–Barr virus infection. Journal of Virology 9:714–716
    [Google Scholar]
15. Polack A., Delius H., Zimber U., Bornkamm G. W. 1984; Two deletions in the Epstein–Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology 133:146–157
    [Google Scholar]
16. Takada K., Zur Hausen H. 1984; Induction of Epstein–Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues. International Journal of Cancer 33:491–496
    [Google Scholar]
17. Tsurumi T., Kobayashi A., Tamai K., Yamada H., Daikoku T., Yamashita Y., Nishiyama Y. 1996; Epstein–Barr virus single- stranded DNA-binding protein: purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology 222:352–364
    [Google Scholar]
18. zur Hausen H., Fresen K. O., Bornkamm G. W. 1978; Epstein–Barr virus genomes and their biological functions: a review. IARC Scientific Publications 24:3–10
    [Google Scholar]